Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan’s Slow Generic Use Caused By Physician Attitudes, Survey Says

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Generic drugs' penetration into the Japanese pharmaceutical market has been languishing below 20 percent, and as many as 83 percent of consumers said their physicians have not recommended they switch from brand drugs, according to a survey released by research firm Ishare, Oct. 20
Advertisement

Related Content

MHLW Reports Little Progress In Japan’s Generic Drug Use
MHLW Reports Little Progress In Japan’s Generic Drug Use
Japan Seeks ¥20 Billion In Spending Cuts With Generic Utilization
Japan Seeks ¥20 Billion In Spending Cuts With Generic Utilization
Japan’s 2007 Generic Sales Rise 9 Percent To ¥425 Billion
Japan’s 2007 Generic Sales Rise 9 Percent To ¥425 Billion
MHLW Doubles Budget For Generic Drug Use Promotion Measures
Advertisement
UsernamePublicRestriction

Register

SC067163

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel